(Q36751225)

16 August 2017

title

Effect of antihypertensive formulation on health service expenditures (English)

1 reference

16 August 2017

Sclar DA

1

1 reference

16 August 2017

Skaer TL

2

1 reference

16 August 2017

Robison LM

3

1 reference

16 August 2017

Chin A

4

1 reference

16 August 2017

Okamoto MP

5

1 reference

16 August 2017

Nakahiro RK

6

1 reference

16 August 2017

Gill MA

7

1 reference

16 August 2017

publication date

1 December 1993

1 reference

Clinical Autonomic Research

16 August 2017

published in

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

363-368

1 reference

Perspectives on systolic hypertension. The Framingham study.

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01829454

Antihypertensive Drug Treatment in Elderly Hypertensive Subjects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01829454

Clinical care of the aging hypertensive patient

21 January 2018

1 reference

12 December 2020

Improved compliance measures: applications in an ambulatory hypertensive drug trial

1 reference

12 December 2020

Clinical acceptability of transdermal clonidine: a large-scale evaluation by practitioners

1 reference

12 December 2020

Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience

1 reference

12 December 2020

Utility of a transdermal delivery system for antihypertensive therapy. Part 2.

1 reference

12 December 2020

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

12 December 2020

Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension

1 reference

12 December 2020

The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Benefits and potential harm of lowering high blood pressure

1 reference

12 December 2020

Therapeutic adherence in the elderly: Transdermal clonidine compared to oral verapamil for hypertension

1 reference

12 December 2020

Transdermal antihypertensive therapy: clinical and metabolic considerations

1 reference

12 December 2020

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

12 December 2020

Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy

1 reference

12 December 2020

The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly.

1 reference

12 December 2020

The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers

1 reference

12 December 2020

Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system

1 reference

12 December 2020

Nonpharmacological approaches to the control of high blood pressure. Final report of the Subcommittee on Nonpharmacological Therapy of the 1984 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Compliance declines between clinic visits

1 reference

12 December 2020

Antihypertensive drug treatment in elderly hypertensive subjects: evidence of protection

1 reference

12 December 2020

Utility of a transdermal delivery system for antihypertensive therapy. Part 1.

1 reference

12 December 2020

Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension

1 reference

12 December 2020

The effect of prescribed daily dose frequency on patient medication compliance

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01829454

1 reference

16 August 2017

1 reference